COVID-19 Clinical Trial
— COFICSOfficial title:
COVID-19 Follow up Intensive Care Studies
Since the SARS-CoV-2 infection is relatively new, the long term attributable burden related
to COVID19 has not been investigated yet. To date, in patients with COVID-19 and their family
members, there is little information on the functional status, cognitive ability, pattern of
return to work, and health related quality of life after the ICU admission.
This study aims to describe the psychological wellbeing, physical - and social functioning of
COVID-19 ICU survivors and their family members up to 12 months following ICU discharge.
| Status | Recruiting |
| Enrollment | 100 |
| Est. completion date | February 1, 2022 |
| Est. primary completion date | February 1, 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - = 18 years old - Ability to speak and write Dutch - Ability to conduct a telephone call - Diagnosed with COVID-19 infection (only in patients) - 48 hours ICU admission (only in patients) Exclusion Criteria: - Refuse to participate - Serious language barrier - Cognitive impairment - Severe psychiatric disorder - Chronic ventilator dependency (only in patients) |
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | University Medical Center Groningen | Groningen |
| Lead Sponsor | Collaborator |
|---|---|
| University Medical Center Groningen | Hanze University of Applied Sciences Groningen |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | General Health | MOS Short-Form General Health Survey (SF-20). The SF-20 contains 20 items and has six dimensions; physical functioning (min. score 6, max. score 12) rolefunctioning (min. score 2, max. score 4) social functioning (min. score 1, max. score 6) mental health (min. score 5, max. score 30) general health (min. score 5, max. score 25) pain (min. score 1, max score 5) All endscores will be transformed to a 100 points scale where a higher score means better functioning. Except for pain where a higher score means more pain. The five mental health questions will be excluded from our questionnaire because the questions are comparable with the HADS. |
3 months post ICU discharge | |
| Primary | General Health | MOS Short-Form General Health Survey (SF-20). The SF-20 contains 20 items and has six dimensions; physical functioning (min. score 6, max. score 12) rolefunctioning (min. score 2, max. score 4) social functioning (min. score 1, max. score 6) mental health (min. score 5, max. score 30) general health (min. score 5, max. score 25) pain (min. score 1, max score 5) All endscores will be transformed to a 100 points scale where a higher score means better functioning. Except for pain where a higher score means more pain. The five mental health questions will be excluded from our questionnaire because the questions are comparable with the HADS. |
6 months post ICU discharge | |
| Primary | General Health | MOS Short-Form General Health Survey (SF-20). The SF-20 contains 20 items and has six dimensions; physical functioning (min. score 6, max. score 12) rolefunctioning (min. score 2, max. score 4) social functioning (min. score 1, max. score 6) mental health (min. score 5, max. score 30) general health (min. score 5, max. score 25) pain (min. score 1, max score 5) All endscores will be transformed to a 100 points scale where a higher score means better functioning. Except for pain where a higher score means more pain. The five mental health questions will be excluded from our questionnaire because the questions are comparable with the HADS. |
12 months post ICU discharge | |
| Primary | Anxiety and Depression | Hospital Anxiety and Depression Scale (HADS). The HADS contains two subscale of 7 items each. Minimal score is 0, maximal score 21 for each subscale where a higher score means a higher burden. | 3 months post ICU discharge | |
| Primary | Anxiety and Depression | Hospital Anxiety and Depression Scale (HADS). The HADS contains two subscale of 7 items each. Minimal score is 0, maximal score 21 for each subscale where a higher score means a higher burden. | 6 months post ICU discharge | |
| Primary | Anxiety and Depression | Hospital Anxiety and Depression Scale (HADS). The HADS contains two subscale of 7 items each. Minimal score is 0, maximal score 21 for each subscale where a higher score means a higher burden. | 12 months post ICU discharge | |
| Primary | Long function | Spirometry test | 6 months post ICU discharge (only in patients) | |
| Primary | Long function | Spirometry test | 12 months post ICU discharge (only in patients) | |
| Primary | Frailty | Clinical Frailty Scale with a single outcome measure summarizing the overall level of fitness. | 3 months post ICU discharge (only in patients) | |
| Primary | Frailty | Clinical Frailty Scale with a single outcome measure summarizing the overall level of fitness. | 6 months post ICU discharge (only in patients) | |
| Primary | Frailty | Clinical Frailty Scale with a single outcome measure summarizing the overall level of fitness. | 12 months post ICU discharge (only in patients) | |
| Primary | Family functioning | McMaster Family Assessment Device (FAD-GF6+). The FAD-GF6+ contains 6 items (min. score 6, max. score 24) where a higher scores indicate a lower caregiver burden. | 6 months post ICU discharge | |
| Primary | Family functioning | McMaster Family Assessment Device (FAD-GF6+). The FAD-GF6+ contains 6 items (min. score 6, max. score 24) where a higher scores indicate a lower caregiver burden. | 12 months post ICU discharge | |
| Primary | Effect of an ICU admission on return to work | Return to work knowing; possible job loss, change of work activities and worsening employment status | 3 months post ICU discharge (only in family members) | |
| Primary | Effect of an ICU admission on return to work | Return to work knowing; possible job loss, change of work activities and worsening employment status | 6 months post ICU discharge | |
| Primary | Effect of an ICU admission on return to work | Return to work knowing; possible job loss, change of work activities and worsening employment status | 12 months post ICU discharge | |
| Secondary | age | age (years) | 24 hours (patient) / 3 months post ICU discharge (family member) | |
| Secondary | Gender | Gender (male/female) | 24 hours (patient) / 3 months post ICU discharge (family member) | |
| Secondary | Social status | Social status (married/living together/ single) | 3 months post ICU discharge | |
| Secondary | APACHE IV | Acute Physiology And Chronic Health Evaluation (APACHE IV). It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): based on several measurements; higher scores correspond to more severe disease and a higher risk of death | 24 hours (only in patients) | |
| Secondary | Comorbidity | Comorbidity ( free text) | 3 months post ICU discharge (only in patients) | |
| Secondary | Body mass index | Body mass index (kg/m2) | 3 months post ICU discharge (only in patients) | |
| Secondary | ICU stay | ICU stay (days) | hospital discharge, an average of 4 weeks (only in patients) | |
| Secondary | Mechanical ventilation | Mechanical ventilation (days) | hospital discharge, an average of 4 weeks (only in patients) | |
| Secondary | Delerium | Delerium (no / yes --> CAM-ICU / DOS score) | hospital discharge, an average of 4 weeks (only in patients) | |
| Secondary | Hospital stay | Hospital stay (days) | hospital discharge, an average of 4 weeks (only in patients) | |
| Secondary | Discharge locationn | Discharge location (home, other hospital, nursing home, revelidation center) | hospital discharge, an average of 4 weeks (only in patients) | |
| Secondary | Mortality | Mortality (no / yes --> date) | 3 months post ICU discharge (only in patients) | |
| Secondary | Mortality | Mortality (no / yes --> date) | 6 months post ICU discharge (only in patients) | |
| Secondary | Mortality | Mortality (no / yes --> date) | 12 months post ICU discharge (only in patients) | |
| Secondary | Relationship with the patient | Relationship with the patient (Partner, sibling, child, other) | 3 months post ICU discharge (only in family members) | |
| Secondary | Educational level | Educational level (low, middle, high) | 3 months post ICU discharge | |
| Secondary | Readmission | Readmission (no / yes --> free text) | 3 months post ICU discharge (only in patients) | |
| Secondary | Health care consumption | Health care consumption (general practicionar, home care, physiotherapist, lung specialist, psychologist, onther (free text)) | 3 months post ICU discharge | |
| Secondary | Health care consumption | Health care consumption (general practicionar, home care, physiotherapist, lung specialist, psychologist, onther (free text)) | 6 months post ICU discharge | |
| Secondary | Health care consumption | Health care consumption (general practicionar, home care, physiotherapist, lung specialist, psychologist, onther (free text)) | 12 months post ICU discharge | |
| Secondary | Weight | Weight (kg) | 3 months post ICU discharge | |
| Secondary | Weight | Weight (kg) | 6 months post ICU discharge | |
| Secondary | Weight | Weight (kg) | 12 months post ICU discharge | |
| Secondary | Hypertensive | Hypertensive (RR) | 3 months post ICU discharge | |
| Secondary | Hypertensive | Hypertensive (RR) | 6 months post ICU discharge | |
| Secondary | Hypertensive | Hypertensive (RR) | 12 months post ICU discharge | |
| Secondary | Thrombosis | Thrombosis (no / yes --> anticoagulant, DVT or PE) | 3 months post ICU discharge | |
| Secondary | Thrombosis | Thrombosis (no / yes --> anticoagulant, DVT or PE) | 6 months post ICU discharge | |
| Secondary | Thrombosis | Thrombosis (no / yes --> anticoagulant, DVT or PE) | 12 months post ICU discharge | |
| Secondary | Diabetes | Diabetes (no /yes --> current insulin level, metformin/ insulin use) | 3 months post ICU discharge | |
| Secondary | Diabetes | Diabetes (no /yes --> current insulin level, metformin/ insulin use) | 6 months post ICU discharge | |
| Secondary | Diabetes | Diabetes (no /yes --> current insulin level, metformin/ insulin use) | 12 months post ICU discharge |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|